Ontrak, Inc. (OTRKP)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -14.41 Million USD | 65.51% |
| 2022 | -42.37 Million USD | -158.52% |
| 2021 | -24.65 Million USD | -12.82% |
| 2020 | -14.92 Million USD | 34.59% |
| 2019 | -21.78 Million USD | -63.37% |
| 2018 | -13.35 Million USD | -12.17% |
| 2017 | -9.94 Million USD | -87.36% |
| 2016 | -12.43 Million USD | 27.38% |
| 2015 | -4.5 Million USD | -98.97% |
| 2014 | -24.23 Million USD | 27.36% |
| 2013 | -1.43 Million USD | 30.04% |
| 2012 | -6.54 Million USD | 24.72% |
| 2011 | -4.56 Million USD | 8.15% |
| 2010 | -18.06 Million USD | 22.47% |
| 2009 | -17.19 Million USD | 60.08% |
| 2008 | -40.72 Million USD | 9.27% |
| 2007 | -45.06 Million USD | -14.84% |
| 2006 | -38.64 Million USD | -61.07% |
| 2005 | -23.99 Million USD | -112.8% |
| 2004 | -11.27 Million USD | -224.93% |
| 2003 | -3.47 Million USD | -895.66% |
| 2002 | -348.51 Thousand USD | -2664.11% |
| 2001 | 13.59 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.68 Million USD | -9.83% |
| 2024 Q2 | -3.72 Million USD | 6.39% |
| 2023 Q3 | -2.19 Million USD | 23.36% |
| 2023 Q2 | -2.86 Million USD | 45.6% |
| 2023 FY | - USD | 65.51% |
| 2023 Q4 | -3.63 Million USD | -65.2% |
| 2023 Q1 | -5.27 Million USD | 26.93% |
| 2022 Q3 | -11.37 Million USD | 8.57% |
| 2022 Q4 | -7.21 Million USD | 36.54% |
| 2022 FY | - USD | -158.52% |
| 2022 Q1 | -11.85 Million USD | -14.25% |
| 2022 Q2 | -12.43 Million USD | -4.88% |
| 2021 Q4 | -10.37 Million USD | -115.98% |
| 2021 FY | - USD | -12.82% |
| 2021 Q2 | -736 Thousand USD | 71.94% |
| 2021 Q1 | -2.62 Million USD | -44.84% |
| 2021 Q3 | -4.8 Million USD | -552.85% |
| 2020 Q4 | -1.81 Million USD | 45.86% |
| 2020 Q1 | -5.57 Million USD | 17.14% |
| 2020 Q3 | -3.34 Million USD | 19.22% |
| 2020 Q2 | -4.14 Million USD | 25.68% |
| 2020 FY | - USD | 34.59% |
| 2019 Q2 | -4.86 Million USD | -96.88% |
| 2019 Q4 | -6.72 Million USD | 17.44% |
| 2019 FY | - USD | -63.37% |
| 2019 Q1 | -2.47 Million USD | -119.25% |
| 2019 Q3 | -8.14 Million USD | -67.44% |
| 2018 Q3 | -3.98 Million USD | 1.77% |
| 2018 FY | - USD | -12.17% |
| 2018 Q1 | -4.12 Million USD | -60.14% |
| 2018 Q2 | -4.06 Million USD | 1.5% |
| 2018 Q4 | -1.12 Million USD | 71.74% |
| 2017 Q1 | -3.08 Million USD | -1681.54% |
| 2017 FY | - USD | -87.36% |
| 2017 Q4 | -2.57 Million USD | 14.99% |
| 2017 Q3 | -3.02 Million USD | 4.42% |
| 2017 Q2 | -3.16 Million USD | -2.72% |
| 2016 Q3 | -2.09 Million USD | -1.55% |
| 2016 Q4 | 195 Thousand USD | 109.3% |
| 2016 Q2 | -2.06 Million USD | 12.5% |
| 2016 FY | - USD | 27.38% |
| 2016 Q1 | -2.36 Million USD | -66.43% |
| 2015 Q1 | -2.69 Million USD | -188.65% |
| 2015 Q4 | -1.41 Million USD | 33.4% |
| 2015 FY | - USD | -98.97% |
| 2015 Q3 | -2.12 Million USD | 13.77% |
| 2015 Q2 | -2.46 Million USD | 8.42% |
| 2014 Q3 | -1.57 Million USD | -234.47% |
| 2014 Q2 | -470 Thousand USD | 70.99% |
| 2014 Q4 | -934 Thousand USD | 40.59% |
| 2014 FY | - USD | 27.36% |
| 2014 Q1 | -1.62 Million USD | -41.24% |
| 2013 Q2 | -1.67 Million USD | 1.24% |
| 2013 Q1 | -1.69 Million USD | 1.91% |
| 2013 FY | - USD | 30.04% |
| 2013 Q4 | -1.14 Million USD | 23.84% |
| 2013 Q3 | -1.5 Million USD | 10.2% |
| 2012 Q3 | -2 Million USD | 9.0% |
| 2012 FY | - USD | 24.72% |
| 2012 Q1 | -2.68 Million USD | 7.52% |
| 2012 Q2 | -2.2 Million USD | 17.9% |
| 2012 Q4 | -1.73 Million USD | 13.58% |
| 2011 Q2 | -2.99 Million USD | 2.73% |
| 2011 Q4 | -2.89 Million USD | -16.9% |
| 2011 FY | - USD | 8.15% |
| 2011 Q1 | -3.07 Million USD | 12.12% |
| 2011 Q3 | -2.48 Million USD | 17.08% |
| 2010 Q2 | -2.99 Million USD | 11.7% |
| 2010 Q3 | -2.6 Million USD | 13.02% |
| 2010 Q4 | -3.49 Million USD | -34.27% |
| 2010 Q1 | -3.39 Million USD | -11.21% |
| 2010 FY | - USD | 22.47% |
| 2009 Q4 | -3.05 Million USD | 16.62% |
| 2009 FY | - USD | 60.08% |
| 2009 Q3 | -3.65 Million USD | 13.68% |
| 2009 Q2 | -4.23 Million USD | 17.26% |
| 2009 Q1 | -5.12 Million USD | -106.57% |
| 2008 Q1 | -14.48 Million USD | -10.52% |
| 2008 Q2 | -10.5 Million USD | 27.48% |
| 2008 Q4 | -2.48 Million USD | 79.32% |
| 2008 Q3 | -11.99 Million USD | -14.14% |
| 2008 FY | - USD | 9.27% |
| 2007 Q3 | -10.12 Million USD | 9.02% |
| 2007 Q2 | -11.12 Million USD | -11.04% |
| 2007 Q1 | -10.02 Million USD | 7.0% |
| 2007 FY | - USD | -14.84% |
| 2007 Q4 | -13.1 Million USD | -29.5% |
| 2006 Q2 | -9.07 Million USD | -2.13% |
| 2006 Q1 | -8.89 Million USD | -4.39% |
| 2006 Q4 | -10.77 Million USD | -8.83% |
| 2006 FY | - USD | -61.07% |
| 2006 Q3 | -9.9 Million USD | -9.05% |
| 2005 Q1 | -4.28 Million USD | -37.31% |
| 2005 FY | - USD | -112.8% |
| 2005 Q4 | -8.51 Million USD | -30.31% |
| 2005 Q3 | -6.53 Million USD | -40.3% |
| 2005 Q2 | -4.65 Million USD | -8.73% |
| 2004 FY | - USD | -224.93% |
| 2004 Q4 | -3.12 Million USD | -9.05% |
| 2004 Q3 | -2.86 Million USD | -19.81% |
| 2004 Q1 | -2.9 Million USD | -19.43% |
| 2004 Q2 | -2.38 Million USD | 17.85% |
| 2003 Q1 | -36.68 Thousand USD | 94.13% |
| 2003 FY | - USD | -895.66% |
| 2003 Q2 | -200.98 Thousand USD | -447.87% |
| 2003 Q4 | -2.43 Million USD | -191.5% |
| 2003 Q3 | -835 Thousand USD | -315.45% |
| 2002 Q4 | -624.62 Thousand USD | -5640.52% |
| 2002 FY | - USD | -2664.11% |
| 2002 Q3 | -10.88 Thousand USD | -103.52% |
| 2002 Q2 | 309.29 Thousand USD | 1486.73% |
| 2002 Q1 | -22.3 Thousand USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 53.928% |
| Augmedix, Inc. | -17.68 Million USD | 18.466% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 104.125% |
| CareCloud, Inc. | -31.29 Million USD | 53.928% |
| HealthEquity, Inc. | 282.41 Million USD | 105.105% |
| iCoreConnect Inc. | -11.87 Million USD | -21.353% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 107.727% |
| Nutex Health, Inc. | -14.58 Million USD | 1.134% |
| Omnicell, Inc. | 60.69 Million USD | 123.754% |
| OneMedNet Corporation | -11.97 Million USD | -20.427% |
| Progyny, Inc. | 64.46 Million USD | 122.363% |
| Renalytix Plc | -28.52 Million USD | 49.455% |
| Schrödinger, Inc. | -171.89 Million USD | 91.614% |
| Simulations Plus, Inc. | 6.13 Million USD | 335.133% |
| SOPHiA GENETICS SA | -70.7 Million USD | 79.61% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | -12.484% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 100.405% |
| Sharecare, Inc. | -67.25 Million USD | 78.565% |
| Aclarion, Inc. | -4.14 Million USD | -248.178% |
| CareMax, Inc. | -590.46 Million USD | 97.559% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | -173.286% |
| Forian Inc. | 2.75 Million USD | 624.163% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | -173.286% |
| HeartBeam, Inc. | 675 Thousand USD | 2235.704% |
| GeneDx Holdings Corp. | -136.46 Million USD | 89.436% |
| SCWorx Corp. | -3.97 Million USD | -262.694% |
| Minerva Surgical, Inc. | -20.07 Million USD | 28.182% |
| Definitive Healthcare Corp. | -241.22 Million USD | 94.024% |
| 10x Genomics, Inc. | -205.11 Million USD | 92.972% |
| Zhongchao Inc. | -4.9 Million USD | -194.063% |
| Accolade, Inc. | -71.19 Million USD | 79.751% |
| MSP Recovery, Inc. | -69.22 Million USD | 79.174% |
| R1 RCM Inc. | 426.2 Million USD | 103.382% |
| Spok Holdings, Inc. | 26.29 Million USD | 154.82% |
| Privia Health Group, Inc. | 27.18 Million USD | 153.035% |
| EUDA Health Holdings Limited | -8.3 Million USD | -73.679% |
| TruBridge, Inc. | -15.39 Million USD | 6.335% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 104.125% |
| Sharecare, Inc. | -67.25 Million USD | 78.565% |
| Health Catalyst, Inc. | -66.46 Million USD | 78.309% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 113.247% |
| Premier, Inc. | 286.08 Million USD | 105.039% |
| HealthStream, Inc. | 59.58 Million USD | 124.193% |
| Certara, Inc. | 23.84 Million USD | 160.46% |
| GeneDx Holdings Corp. | -136.46 Million USD | 89.436% |
| Ontrak, Inc. | -14.41 Million USD | -0.0% |
| SHL Telemedicine Ltd. | 3.28 Million USD | 539.042% |
| CareCloud, Inc. | -31.29 Million USD | 53.928% |
| EUDA Health Holdings Limited | -8.3 Million USD | -73.679% |
| HeartBeam, Inc. | 675 Thousand USD | 2235.704% |
| Mangoceuticals, Inc. | -9.18 Million USD | -56.908% |
| CareMax, Inc. | -590.46 Million USD | 97.559% |
| Healthcare Triangle, Inc. | -4.1 Million USD | -251.267% |
| National Research Corporation | 45.98 Million USD | 131.349% |
| Aclarion, Inc. | -4.14 Million USD | -248.178% |
| OptimizeRx Corporation | -21.3 Million USD | 32.346% |